Peli BioThermal, the global name in temperature controlled packaging, has announced production of its newest addition to its range of bulk shippers, the CoolPall™ Flex, …
AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy – …
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has entered into a significant enterprise agreement with leading …
PCI’s Tredegar site is the latest site to offer full Serialization services to global customers PCI Pharma Services (PCI) is pleased to announce the installation …
Commissioner outlines new policies for drugs that have Risk Evaluation and Mitigation Strategy (REMS) requirements. In a recent statement, US Food and Drug Administration (FDA) …
DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are …
HGF Ltd is delighted to announce that from the 1st of May 2018, Kieran Killough and Dr Susan Keston have been promoted to Partner, increasing …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
